Patterson CompaniesPDCO
PDCO
About: Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
Employees: 7,600
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
13% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 92
3.93% less ownership
Funds ownership: 87.92% [Q2] → 83.99% (-3.93%) [Q3]
12% less funds holding
Funds holding: 315 [Q2] → 277 (-38) [Q3]
13% less capital invested
Capital invested by funds: $1.86B [Q2] → $1.62B (-$243M) [Q3]
14% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $11.9M
51% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 75
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$22
29%
downside
Avg. target
$27
12%
downside
High target
$31
2%
upside
6 analyst ratings
0 positive
0%
6 neutral
100%
0 negative
0%
Morgan Stanley Erin Wright 48% 1-year accuracy 11 / 23 met price target | 2%upside $31 | Equal-Weight Maintained | 17 Dec 2024 |
Baird Jeff Johnson 46% 1-year accuracy 6 / 13 met price target | 0%upside $31 | Neutral Maintained | 12 Dec 2024 |
Leerink Partners Michael Cherny 58% 1-year accuracy 19 / 33 met price target | 2%upside $31 | Market Perform Downgraded | 11 Dec 2024 |
Piper Sandler Jason Bednar 50% 1-year accuracy 19 / 38 met price target | 22%downside $24 | Neutral Maintained | 6 Dec 2024 |
Stifel Jonathan Block 22% 1-year accuracy 4 / 18 met price target | 22%downside $24 | Hold Maintained | 5 Dec 2024 |
Financial journalist opinion
Based on 22 articles about PDCO published over the past 30 days
Positive
Zacks Investment Research
5 days ago
PDCO Stock Gains on the News of Acquisition Deal With Patient Square
Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.
Positive
Benzinga
1 week ago
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.
Positive
Seeking Alpha
1 week ago
Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade)
Patterson Companies' shares surged 35.9% after announcing an all-cash buyout by Patient Square Capital, valuing the company at $4.1 billion. Despite the buyout, some investors feel the deal leaves money on the table, but the stock's appreciation is a net positive. The go-shop period allows management to seek better offers, suggesting potential for a higher bid, making it wise to hold shares.
Neutral
PRNewsWire
1 week ago
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO
NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Patterson Companies, Inc. (NASDAQ: PDCO ), relating to the proposed merger with Patient Square Capital.
Positive
Benzinga
1 week ago
Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.
Neutral
Investors Business Daily
1 week ago
Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?
Patterson Companies stock launched Wednesday after the dental outfit said it agreed to a $4.1 billion takeover deal from Patient Square. The post Patterson Launches On $4.1 Billion Takeover.
Neutral
Business Wire
1 week ago
PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.
Positive
Barrons
1 week ago
Patterson Cos. to Be Acquired by Patient Square Capital for $4.1 Billion
Shareholders will receive $31.35 in cash per share under terms of the deal.
Neutral
Business Wire
1 week ago
Shareholder Alert: Ademi LLP Investigates Whether Patterson Companies, Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Patterson (Nasdaq: PDCO) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Patterson shareholders will receive $31.35 in cash per share. Patterson insiders will receive substanti.
Neutral
Business Wire
1 week ago
Patterson Companies Announces Definitive Agreement to Be Acquired by Patient Square Capital for $31.35 Per Share in Cash
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson's 30 calendar day volume-weighted average price (VWAP) endin.
Charts implemented using Lightweight Charts™